Abstract:
PURPOSE: A ginseng extract containing low polarity ginsenoside in high concentration, which has anti-obesity effect is provided to reduce the accumulation of lipid in an adipocyte and used as a composition for anti-obesity. CONSTITUTION: A method for manufacturing a ginseng extract comprises: a step of extracting a ginseng with 20-40 v/v% of methanol or ethanol and 80 ~ 99 v/v% of methanol or ethanol; a step of culturing the extract in pH 1.3-2 of artificial gastric juice; and a step of adding serous fluid and culturing at pH 7-8.
Abstract:
본 발명은 데하이드로글리아스페린 디(dehydroglyasperin D; DHGA-D)를 유효성분으로 포함하는 것을 특징으로 하는 피부질환 예방 또는 치료용 조성물에 관한 것으로, DHGA-D가 MMP-1과 직접 결합하여, MMP-1의 활성을 감소시키고, S-UV 조사에 의해 증가한 MMP-1의 발현을 억제함이 확인되었다. 또한, S-UV의 조사에 의해 증가한 COX-2의 발현과 p38과 JNK의 인산화를 감소시키는 효과도 확인되었다. 따라서, 본 발명의 DHGA-D는 피부질환 예방 또는 치료용 조성물로 개발되어 사용될 수 있다.
Abstract:
PURPOSE: A pharmaceutical composition containing dehydroglyasperin C is provided to suppress nerve cell injury and apoptosis and to improve cognitive function. CONSTITUTION: A pharmaceutical composition for treating cognitive function reduction contains dehydroglyasperin C of chemical formula 1 as an active ingredient. The cognitive function reduction is caused by stroke, dementia, Alzheimer's disease, Parkinson's disease, Huntington' disease, Pick disease, or Creutzfeldt-Jakob disease. A health functional food for reducing cognitive function reduction contains dehydroglyasperin C of chemical formula 1. The health functional food is a tablet, capsule, pill, or liquid.
Abstract:
PURPOSE: A composition containing dehydroglyasperin D(DHGA-D) for preventing or treating cutaneous disorders is provided to suppress MMP-1 expression and reduce p38 and JNK phosphorylation. CONSTITUTION: A composition for preventing or treating cutaneous disorders contains 10uM-1mM of dehydroglyasperin D(DHGA-D) as an active ingredient. The cutaneous disorders include skin aging, dermatitis, or skin cancer. The composition is a pharmaceutical composition. The formulation of the pharmaceutical composition includes plasters, granules, lotions, liniments, lemonades, aromatic waters, powders, syrups, ophthalmic ointments, liquids and solutions, aerosols, extracts, elixirs, ointments, fluid extracts, emulsions, suspensions, decoctions, infusions, pills, or soft or hard gelatin capsules.
Abstract:
PURPOSE: A composition containing dehydroglyasperin C, dehydroglyasperin D, or isoangustone A as an active ingredient for skin whitening is provided to suppress tyrosinase activity and melanogenesis, and to ensure excellent skin whitening effect. CONSTITUTION: A cosmetic composition for skin whitening contains dehydroglyasperin C of chemical formula 1 as an active ingredient. The cosmetic composition contains dehydroglyasperin D of chemical formula 2 as an active ingredient. The cosmetic composition for skin whitening contains isoangustone A of chemical formula 3 as an active ingredient. The compounds are derived from Glycyrrhizae radix.
Abstract:
PURPOSE: A composition for protecting liver, which containing red ginseng and Pueraria lobata Ohwi is provided to improve liver function without adding additional active ingredient. CONSTITUTION: A composition for protecting liver comprises crude extract of red ginseng, Pueraria lobata Ohwi extract, and vitamin complex containing vitamin C, vitamin B1, vitamin B2 and vitamin B6 as active ingredient. The crude extract is obtained by adding 0.7-3 v/v% of acetic acid and extracting at 80-100°C for two to three hours. The crude extract of the red ginseng and the Pueraria lobata Ohwi extract are mixed together in mixture ratio of 1:1.3-1.7.